October 26-27 2020 Boston, MA
Andrew Radin is Co-Founder and Chief Executive Officer of twoXAR, an artificial intelligence-driven drug discovery company. The company leverages its computational platform to identify promising drug candidates, de-risks the opportunities through preclinical studies, and progresses drug candidates to the clinic through industry and investor partnerships. Andrew developed the company’s proprietary algorithm and leads product development. Prior to co-founding twoXAR, He held Chief Technology Officer roles at several early stage companies where he managed teams as large as a hundred technologists distributed around the world. Andrew studied biomedical informatics in Stanford University’s SCPD graduate program and holds Master of Science and Bachelor of Science degrees in Computer Science from Rochester Institute of Technology.